Our Mission

To develop safe and transformative molecular therapies for Congenital Disorders of Glycosylation (CDG) and other genetic diseases.

Our Executive Leadership Team

Marisa Brothwell, PhD

Co-founder, Chief Executive Officer

Kent Lai, PhD, MBA

Co-founder, Chief Scientific Officer

Won Yong Lee, DVM, PhD

Co-founder, Chief Operating Officer